Pharmacyclics Inc (NASDAQ:PCYC)

215.93
Delayed Data
As of Feb 27
 -1.89 / -0.87%
Today’s Change
82.51
Today|||52-Week Range
231.09
+76.62%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$16.4B

Company Description

Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The company has three product candidates in clinical development and several preclinical molecules in lead optimization. Its clinical development and product candidates are small-molecule enzyme inhibitors designed to target key biochemical pathways involved in human diseases with critical unmet needs. Pharmacyclics was founded on April 19, 1991 and is headquartered in Sunnyvale, CA.

Contact Information

Pharmacyclics, Inc.
995 East Arques Avenue
Sunnyvale California 94085-4521
P:(408) 774-0330
Investor Relations:

Employees

Shareholders

Mutual fund holders47.60%
Individual stakeholders33.71%
Other institutional30.40%

Top Executives

Robert W. DugganChairman & Chief Executive Officer
Mahkam ZanganehChief Operating Officer
Manmeet Singh SoniChief Financial Officer
James N. LowderVice President-Clinical Development
Jesse Seton McGreivyChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account